Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $59.2504 (0.01%) ($58.6164 - $59.9287) on Mon. Jul. 6, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.21% (three month average) | RSI | 59 | Latest Price | $59.2504(0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.7% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) IBB(48%) VYM(48%) IVE(47%) SPY(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.605% in a week (0% probabilities). VIXM(-22%) TLT(-15%) UUP(-8%) IGOV(-4%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.605% (StdDev 1.21%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
Resistance Level | $59.41 | 5 Day Moving Average | $58.94(0.53%) | 10 Day Moving Average | $59.79(-0.9%) | 20 Day Moving Average | $59.41(-0.27%) | To recent high | -3.2% | To recent low | 19.4% | Market Cap | $104.534b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |